SINGAPORE (Nov 11): iX Biopharma has reported net losses of $776,000 for 1Q17, an improvement of 68% over the net losses of $2.4 million in 1Q16.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $4.99/month*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply